(Q73739613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

6 November 2019

main subject

1 reference

S Vanderschueren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Dens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Kerdsinchai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W Desmet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Vrolix

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F De Man

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Van den Heuvel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Hermans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Collen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Van de Werf

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

213-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

Rationale for bolus t-PA therapy to improve efficacy and safety

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Novel and Innovative Dosing Regimens in Thrombolytic Therapy for Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

High yield production and purification of recombinant staphylokinase for thrombolytic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

The open-artery theory is alive and well--again

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

Recombinant staphylokinase variants with altered immunoreactivity. IV: Identification of variants with reduced antibody induction but intact potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970127-3

10.1016/S0002-8703(97)70127-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9313600%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference